New Collagen Rope Patent for CelGro Platform Technology; Managing Director Paul Anderson said: “There are currently no biological off-the-shelf solutions that mimic human ligament to enable the optimal repair of ACL injuries. The CelGro® collagen rope addresses this problem. It is designed to augment ACL reconstruction without the need to harvest the patient’s hamstring or patella tendon and will disrupt the sports injury repair marketby dramatically improving ACL surgery outcomes. We are extremely excited by the potential of this novel technology and I look forward to releasing the pre-clinical results in Q3 CY2021”
http://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02378248-6A1034350?access_token=83ff96335c2d45a094df02a206a39ff4
- Forums
- ASX - By Stock
- OCC
- FDA significance
OCC
orthocell limited
Add to My Watchlist
3.57%
!
$1.16

FDA significance, page-389
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
0.040(3.57%) |
Mkt cap ! $285.7M |
Open | High | Low | Value | Volume |
$1.13 | $1.20 | $1.13 | $827.5K | 709.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7075 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7075 | 1.160 |
2 | 53542 | 1.140 |
1 | 4405 | 1.135 |
3 | 65555 | 1.130 |
2 | 5166 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 5000 | 1 |
1.180 | 1545 | 1 |
1.195 | 15703 | 5 |
1.200 | 30000 | 2 |
1.205 | 3900 | 1 |
Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |